Net Loss per Common Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Stock options and performance stock options | ||
| Net (Loss) Income per Common Share [Line Items] | ||
| Potentially dilutive securities (in shares) | 70,951,737 | 135,593,216 |
| Restricted stock units and performance restricted stock units (non-vested) | ||
| Net (Loss) Income per Common Share [Line Items] | ||
| Potentially dilutive securities (in shares) | 60,286,608 | 53,111,118 |
| March 2020 CVARs | ||
| Net (Loss) Income per Common Share [Line Items] | ||
| Potentially dilutive securities (in shares) | 0 | 17,548,368 |
| Earn-Out Shares (non-vested) | ||
| Net (Loss) Income per Common Share [Line Items] | ||
| Potentially dilutive securities (in shares) | 0 | 3,080,387 |
| Other stock based awards and instruments issued | ||
| Net (Loss) Income per Common Share [Line Items] | ||
| Potentially dilutive securities (in shares) | 415,929 | 4,485,265 |